Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today April 27
May 17, 2023 10:55
Parse Biosciences Expands Global Access to Israel
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Israel-based Ornat Biochemicals and Laboratory Equipment to extend
May 17, 2023 09:40
UK’s Nurse Margaret Wins the Coveted Aster Guardians Global Nursing Award 2023
Margaret Helen Shepherd from UK has been announced as the winner of the Aster Guardians Global Nursing Award 2023 in a prestigious award ceremony held at Queen Elizabeth II Centre in London. The winne
May 16, 2023 17:20
Carbios Recognized as a Flagship Start-up in French Green Innovation at the Choose France Summit
Regulatory News: Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, has been s
May 16, 2023 15:50
AOP Health congratulates FROM on its great scientific work in the field of myeloproliferative neoplasms
Fondazione per la Ricerca dell'Ospedale di Bergamo (FROM) announced the publication of the latest results from the LOW-PV trial in the NEJM Evidence. The findings support a paradigm shift in the tr
May 15, 2023 10:02
Nagasaki University Presented Results Of a Specified Clinical Trial On The Use of L. lactis strain Plasma For Patients With COVID-19
Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus. lactis strain Plasma[1](L.lactis Plasma, a postbiotic), researched and developed by
May 14, 2023 10:15
AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera
AOP Health announced new results on ropeginterferon alfa-2b (BESREMi®) from its clinical study CONTINUATION-PV in patients with polycythaemia vera (PV), a rare blood cancer. Professor Heinz Gisslinger
May 12, 2023 14:45
Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2022 (period ended March 31, 2023), delivering or exceeding management guidance, driven by the performance of its
May 12, 2023 09:35
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it will provide its inactivated COVID-19 vaccine, CoronaVac®
May 11, 2023 13:29
Oncocross Completes Phase 1 Global Clinical Trial of OC514, Treatment for Sarcopenia
Oncocross, a Seoul-based AI drug discovery and development biotech, announced the completion of phase 1 global clinical trial of OC514, a treatment targeting sarcopenia and other rare muscular disease
May 10, 2023 17:22
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned maintenance dose. The
May 10, 2023 15:40
Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases
Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 study (NCT05658107) to assess the safety, tolerab
May 10, 2023 14:50
Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor
Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, today announced that Roche has acquired the global rights to Zion’s lead program, ZN-A-10
May 10, 2023 11:30
Kenvue Announces Closing of Initial Public Offering
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) the world’s largest pure-play consumer health company by revenue, today announced the closing of its initial public offering (“IPO”) of 198,734,444 shares of its co
May 10, 2023 10:15
Four Analyses of Data for REBYOTA™ (fecal microbiota, live - jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023
Ferring Pharmaceuticals today announced three oral presentations and one poster presentation at Digestive Disease Week® (DDW 2023) for REBYOTA™ (fecal microbiota, live - jslm) a first-in-class single-
May 09, 2023 16:55
Amicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows
Amicogen, a leading biotech company specializing in industrial enzyme production and drug development, has partnered with Lysando, an innovative biotech company with expertise in the development of an
May 09, 2023 10:40
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
Masimo (NASDAQ: MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch for use in its telehealth and telemedicin
May 08, 2023 09:05
Aquyre Biosciences Announces Appointment of F. Samuel Eberts III as CEO and Chairman of the Board of Directors & Founder Bertrand de Poly as Chief Strategy & Technology Officer
Aquyre Biosciences, Inc. today announced the appointment of F. Samuel Eberts III as Chief Executive Officer and Chairman of its Board of Directors. Founder Bertrand de Poly will assume the role of Chi
May 07, 2023 14:45
Kenvue to Begin Trading on the New York Stock Exchange
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will begin trading today on the New York Stock Exchange under the ticker symbol “KVUE” in connect
May 03, 2023 14:00
SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
Boehringer Ingelheim announced today that spesolimab (marketed as SPEVIGO®) received Breakthrough Therapy Designation (BTD) as an investigational treatment for the prevention of flares in adolescents
April 27, 2023 11:45
New Point-of-Care Diagnostics Video from Nordson EFD Explains How Precise Fluid Dispensing Improves Production Accuracy
Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces a new animated video focused on point-of-care diagnostic dispensing applications w
April 25, 2023 09:30
MDimune Wins Bronze at 2023 Edison Awards
MDimune Inc., a biotech company developing BioDrone™ platform technology, has won the Bronze Award at the 2023 Edison Awards. The company has won in the Health, Medical & Biotech category for its next
April 23, 2023 10:13
Dental Monitoring files a new claim against Get-Grin Inc. for patent infringement relating to its DM ScanBox device
Dental Monitoring has filed a lawsuit against Get-Grin Inc. (“Get Grin”) with the United States District Court for the District of Delaware alleging infringement of two of its patents (U.S. Patent Nos
April 20, 2023 15:40
Aleph Farms Launches New Product Brand Aleph Cuts
Aleph Farms, a food technology company designing new ways to grow quality animal products, today announced the launch of its first product brand, Aleph Cuts. Under the Aleph Cuts brand, the company wi
April 19, 2023 14:57
Augmented Reality: Patient Experience Trumps Misconceptions Around Injectables
New global research,[2] sponsored by Galderma and released today by leading filler brand Restylane®, has revealed the prevalent societal misconceptions and stereotypes facing the aesthetics industry.
April 19, 2023 14:30
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its Sa
April 19, 2023 11:10
Armis Announces Significant Business Momentum in Healthcare
HIMSS - Armis, the leading asset visibility and security company, today announced significant business momentum in the healthcare sector driven by healthcare and life sciences companies choosing the A
April 18, 2023 17:07
Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health
Ferring Pharmaceuticals and BioInnovation announce a new strategic collaboration to accelerate innovation in women’s health. BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals A/S
April 18, 2023 10:10
KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment of J.D. Mowery as Chief Executive Officer (CEO). Widely respected as an innovative biotech l
April 16, 2023 15:18
AristaCare Health Services: The Future of Post-Acute Rehab and Long-Term Care
For over 20 years, AristaCare Health Services has been providing exceptional post-acute rehabilitation, memory care, and long-term care services to patients and residents in New Jersey and Pennsylvani
April 14, 2023 11:00
Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG
Lysando AG - market leader in the field of antimicrobial proteins - is pleased to announce that Dr. Yong Chul Shin has joined the team as CSO in April. Dr. Shin will be responsible for leading the com
April 13, 2023 13:55
Berry Consultants Releases FACTS 7 Clinical Trial Simulator
Berry Consultants, LLC announced today that FACTS 7 was released to existing users and is now available to all new clients. FACTS (Fixed and Adaptive Clinical Trial Simulator) is the most powerful, fl
April 12, 2023 16:30
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue
Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients on evobrutinib and pat
April 06, 2023 11:55
Panda Biotech Announces Landmark Equity Partnership With Southern Ute Growth Fund Aka-Ag, LLC
Panda Biotech announces a landmark equity partnership deal between the Panda High Plains Hemp Gin™ (PHPHG) project and the Southern Ute Indian Tribe Growth Fund (Growth Fund). The Growth Fund is owned
April 06, 2023 09:35
Aleph Farms Joins the United Nations Global Compact
Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has joined the United Nations Global Compact, a voluntary leadership platform for
April 06, 2023 09:30
Top 10 Finalist Nurses Announced for Aster Guardians Global Nursing Award 2023 Worth US $250,000
Aster Guardians Global Nursing Award - an award instituted to recognize inspirational work done by nurses from around the world - has announced its top 10 finalists hailing from across the world. They
April 05, 2023 17:10
Technology Holdings Advises SUAZIO, a Data-Driven Life Sciences and MedTech Strategic Consultancy, on Its Sale to NAMSA
Technology Holdings, a global boutique investment bank with offices in North America, Europe and the Asia-Pacific is pleased to announce that it has acted as exclusive financial advisor to SUAZIO, a l
April 05, 2023 11:00
DentalMonitoring Announces Braces Monitoring Innovations
DentalMonitoring continues to set the standard in AI-powered orthodontic solutions, with two innovative features that allow doctors to better visualize progress and obstacles throughout treatment. An
April 05, 2023 09:55
Brazilian Healthcare Technology Company Secures Sensitive Data With Thales
Thales, a global technology leader, continues to create partnerships to take its innovations to various sectors of society, including health. The latest collaboration is with Funcional HealthTech in B
April 04, 2023 11:10
Wyss Center Geneva Appoints Erwin Böttinger as new Chief Executive Officer
The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the appointment of Prof. Dr. med. Erwin Böttinger as its new Chief Executive O
April 04, 2023 10:14
TissenBioFarm Selected for SAMSUNG Welstory’s Accelerating Program
TissenBioFarm, a cultivated meat startup based in South Korea, has been selected for the SAMSUNG Welstory TechUP+ program. SAMSUNG Welstory and startup accelerator FuturePlay discover and support
April 02, 2023 10:13
Joe Kiani Wins 2023 Robert L. Wears Patient Safety Leadership Award
Joe Kiani, founder of the Patient Safety Movement Foundation (PSMF), has been awarded the 2023 Robert L. Wears Patient Safety Leadership Award in the individual category, along with Dr. Kathryn Kellog
March 31, 2023 13:45
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
Takeda (TSE:4502/NYSE:TAK) announced that its Board of Directors today decided that it will propose a new candidate for independent external director at the 147th Ordinary Meeting of Shareholders on J
March 31, 2023 09:39
Takeda Announces Results From Phase 4 Vedolizumab Study in Patients With Chronic Pouchitis Published in New England Journal of Medicine
Takeda (TSE:4502/NYSE:TAK) today confirmed that the New England Journal of Medicine (NEJM) has published positive data from the Phase 4 EARNEST study of vedolizumab for the treatment of chronic pouchi
March 30, 2023 14:35
AMWC 2023: Data From Sculptra® Cheek Wrinkle and Alluzience® Star Studies Reinforce Strength of Galderma’s Broad Aesthetic Portfolio
Galderma will be presenting the latest data from the Sculptra® (injectable poly-L-lactic acid, PLLA-SCA) Cheek Wrinkle and Alluzience® (abobotulinumtoxinA solution) STAR studies at the 21st Aesthetic
March 30, 2023 13:45
Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies
Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T
March 29, 2023 17:16
Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth
Boehringer Ingelheim today reported a strong performance in 2022, a year in which 30 million patients benefited from its innovative medicines, while deepening investments in the search for new treatme
March 29, 2023 13:40
ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)
ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced that the first subject has been enrolled in the clinical trial with an FDA-approved IND evaluating Nantheia™ A1002
March 28, 2023 10:30
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination
Graf Acquisition Corp. IV (NYSE: GFOR) (“Graf”), a NYSE-listed special purpose acquisition company founded by serial SPAC founder James Graf, and NKGen Biotech, Inc. (“NKGen Biotech”), a biotechnology
March 28, 2023 09:40
Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO® (avelumab)
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVE
March 22, 2023 13:35
José Baselga Research Fund Announces First-Ever Grant to Advance Prion Disease Research
The José Baselga Research Fund (JBRF), supported by Alexion, AstraZeneca Rare Disease, today announced the initiation of the Global José Baselga Research Grant (Baselga Grant), an annual $75,000 grant
«
6
7
8
9
10
»
50 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice